{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T22:11:14Z","timestamp":1780611074882,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Open Project of Henan Clinical Research Center of Infectious Diseases","award":["KFKT202411"],"award-info":[{"award-number":["KFKT202411"]}]},{"name":"Open Project of Henan Clinical Research Center of Infectious Diseases","award":["KFKT202411"],"award-info":[{"award-number":["KFKT202411"]}]},{"name":"Open Project of Henan Clinical Research Center of Infectious Diseases","award":["KFKT202411"],"award-info":[{"award-number":["KFKT202411"]}]},{"name":"Open Project of Henan Clinical Research Center of Infectious Diseases","award":["KFKT202411"],"award-info":[{"award-number":["KFKT202411"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05821-4","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:57:32Z","timestamp":1751389052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Survival analysis of PLWH on antiretroviral therapy in Henan Province from 2004 to 2024"],"prefix":"10.1038","volume":"15","author":[{"given":"Meng","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"5821_CR1","unstructured":"UNAIDS. 2024 global AIDS report \u2014 The Urgency of Now: AIDS at a Crossroads. ; (2024). Available from: https:\/\/www.unaids.org\/en\/resources\/documents\/2024\/global-aids-update-2024"},{"issue":"1","key":"5821_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11904-019-00478-x","volume":"17","author":"W Cao","year":"2020","unstructured":"Cao, W., Hsieh, E. & Li, T. Optimizing treatment for adults with HIV\/AIDS in china: successes over two decades and remaining challenges. Curr. HIV\/AIDS Rep. 17 (1), 26\u201334 (2020).","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"11","key":"5821_CR3","first-page":"1674","volume":"31","author":"P Feng","year":"2024","unstructured":"Feng, P. China still faces multiple challenges in AIDS prevention and control work. Chin. Contemp. Med. 31 (11), 1674\u20134721 (2024).","journal-title":"Chin. Contemp. Med."},{"key":"5821_CR4","doi-asserted-by":"publisher","first-page":"100082","DOI":"10.1016\/j.dialog.2022.100082","volume":"1","author":"E Senu","year":"2022","unstructured":"Senu, E. et al. Factors associated with anti-retroviral therapy (ART) adherence among adult people living with HIV (PLWH): A 5-year retrospective multi-centre study in kumasi, Ghana. Dialogues Health. 1, 100082 (2022).","journal-title":"Dialogues Health"},{"issue":"1","key":"5821_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/1570162X21666230123151639","volume":"21","author":"S Sinha","year":"2023","unstructured":"Sinha, S. et al. Survival of persons living with HIV\/AIDS: A multicentric study from India. Curr. HIV Res. 21 (1), 81\u201387 (2023).","journal-title":"Curr. HIV Res."},{"key":"5821_CR6","doi-asserted-by":"publisher","first-page":"1068664","DOI":"10.3389\/fpubh.2023.1068664","volume":"11","author":"X Tian","year":"2023","unstructured":"Tian, X. et al. Global, regional, and National HIV\/AIDS disease burden levels and trends in 1990\u20132019: A systematic analysis for the global burden of disease 2019 study. Front. Public. Health. 11, 1068664 (2023).","journal-title":"Front. Public. Health"},{"key":"5821_CR7","doi-asserted-by":"publisher","first-page":"989127","DOI":"10.3389\/fpubh.2022.989127","volume":"10","author":"Z Zhu","year":"2022","unstructured":"Zhu, Z. et al. Survival and risk factors associated with mortality in people living with HIV from 2005 to 2018 in nanjing, China. Front. Public. Health. 10, 989127 (2022).","journal-title":"Front. Public. Health"},{"key":"5821_CR8","doi-asserted-by":"publisher","first-page":"1208155","DOI":"10.3389\/fcimb.2023.1208155","volume":"13","author":"R Jiang","year":"2023","unstructured":"Jiang, R. et al. Survival and prognostic factors of progressive multifocal leukoencephalopathy in people living with HIV in modern ART era. Front. Cell. Infect. Microbiol. 13, 1208155 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"11","key":"5821_CR9","doi-asserted-by":"publisher","first-page":"e0277039","DOI":"10.1371\/journal.pone.0277039","volume":"17","author":"T Ndoro","year":"2022","unstructured":"Ndoro, T., Ndlovu, N. & Nyasulu, P. Factors associated with ART adherence among HIV-positive adherence club members in Ekurhuleni metropolitan municipality, South africa: A cross-sectional study. PLoS One. 17 (11), e0277039 (2022).","journal-title":"PLoS One"},{"issue":"6","key":"5821_CR10","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s15010-021-01668-9","volume":"49","author":"Z Yang","year":"2021","unstructured":"Yang, Z. et al. Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan province, China (2018\u20132020). Infection 49 (6), 1195\u20131202 (2021).","journal-title":"Infection"},{"key":"5821_CR11","unstructured":"Department of Infectious & Diseases, P. U. M. C. H. Chinese Academy of Medical Sciences, Beijing, China China AIDS Treatment Guidelines Peking Union Medical College Journal. 15(6):1261\u20131288(2024). (2024) Edition."},{"issue":"11","key":"5821_CR12","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S2352-4642(22)00219-X","volume":"6","author":"J Zhang","year":"2022","unstructured":"Zhang, J., Ma, B., Han, X., Ding, S. & Li, Y. Global, regional, and National burdens of HIV and other sexually transmitted infections in adolescents and young adults aged 10\u201324 years from 1990 to 2019: a trend analysis based on the global burden of disease study 2019. Lancet Child. Adolesc. Health. 6 (11), 763\u2013776 (2022).","journal-title":"Lancet Child. Adolesc. Health"},{"issue":"22","key":"5821_CR13","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1097\/CM9.0000000000002500","volume":"135","author":"Y Lu","year":"2022","unstructured":"Lu, Y. et al. Changes of human immunodeficiency virus (HIV) burden globally and in China over three decades: a secondary analysis of global HIV statistics. Chin. Med. J. (Engl). 135 (22), 2690\u20132698 (2022).","journal-title":"Chin. Med. J. (Engl)"},{"issue":"1","key":"5821_CR14","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1186\/s12889-023-15662-3","volume":"23","author":"S Ke","year":"2023","unstructured":"Ke, S. et al. Survival times of HIV\/AIDS in different AIDS diagnostic and treatment guidelines from 2006 to 2020 in liuzhou, China. BMC Public. Health. 23 (1), 1745 (2023).","journal-title":"BMC Public. Health"},{"issue":"9","key":"5821_CR15","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1007\/s10461-024-04396-x","volume":"28","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Survival analysis and immune differences of HIV Long-Term Non-progressors in Xinjiang china: A 12-Year prospective cohort observation. AIDS Behav. 28 (9), 3151\u20133160 (2024).","journal-title":"AIDS Behav."},{"key":"5821_CR16","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.2147\/IDR.S463262","volume":"17","author":"L Ye","year":"2024","unstructured":"Ye, L. et al. Survival analysis of antiretroviral treatment for PLWH in Sichuan province, china, 2003\u20132022: A large retrospective cohort study. Infect. Drug Resist. 17, 3133\u20133143 (2024).","journal-title":"Infect. Drug Resist."},{"key":"5821_CR17","doi-asserted-by":"publisher","first-page":"1327264","DOI":"10.3389\/fpubh.2024.1327264","volume":"12","author":"JF Pu","year":"2024","unstructured":"Pu, J. F. & Wu, J. Survival analysis of PLWHA undergoing combined antiretroviral therapy: exploring long-term prognosis and influencing factors. Front. Public. Health. 12, 1327264 (2024).","journal-title":"Front. Public. Health"},{"key":"5821_CR18","unstructured":"Organization, W. H. Global HIV programme: HIV data and statistics. ; (2021). Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics"},{"issue":"3","key":"5821_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.5582\/ddt.2023.01007","volume":"17","author":"H Tanaka","year":"2023","unstructured":"Tanaka, H., Satoh, M., Takigawa, M., Onoda, T. & Ishii, T. Characteristics of adverse event reports among people living with human immunodeficiency virus (HIV) in japan: data mining of the Japanese adverse drug event report database. Drug Discov Ther. 17 (3), 183\u2013190 (2023).","journal-title":"Drug Discov Ther."},{"issue":"1","key":"5821_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12981-021-00397-1","volume":"18","author":"W Manosuthi","year":"2021","unstructured":"Manosuthi, W., Charoenpong, L. & Santiwarangkana, C. A retrospective study of survival and risk factors for mortality among people living with HIV who received antiretroviral treatment in a resource-limited setting. AIDS Res. Ther. 18 (1), 71 (2021).","journal-title":"AIDS Res. Ther."},{"issue":"23","key":"5821_CR21","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1097\/CM9.0000000000001842","volume":"134","author":"JJ Xu","year":"2021","unstructured":"Xu, J. J. et al. Prevention and control of HIV\/AIDS in china: lessons from the past three decades. Chin. Med. J. (Engl). 134 (23), 2799\u20132809 (2021).","journal-title":"Chin. Med. J. (Engl)"},{"issue":"1","key":"5821_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12879-022-07281-x","volume":"22","author":"S Feng","year":"2022","unstructured":"Feng, S. et al. A comparative analysis on characteristics and mortalities of four key transmission populations on antiretroviral therapy: a retrospective cohort study in Northwest China. BMC Infect. Dis. 22 (1), 299 (2022).","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"5821_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s13104-023-06625-3","volume":"16","author":"NS Muhie","year":"2023","unstructured":"Muhie, N. S. & Tegegne, A. S. Predictors for CD4 cell count and hemoglobin level with survival time to default for HIV positive adults under ART treatment at university of Gondar comprehensive and specialized hospital, Ethiopia. BMC Res. Notes. 16 (1), 357 (2023).","journal-title":"BMC Res. Notes"},{"issue":"4","key":"5821_CR24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/infdis\/jiab433","volume":"225","author":"BA Peters","year":"2022","unstructured":"Peters, B. A. et al. T-Cell immune dysregulation and mortality in women with human immunodeficiency virus. J. Infect. Dis. 225 (4), 675\u2013685 (2022).","journal-title":"J. Infect. Dis."},{"key":"5821_CR25","doi-asserted-by":"publisher","first-page":"1397743","DOI":"10.3389\/fcimb.2024.1397743","volume":"14","author":"L Fan","year":"2024","unstructured":"Fan, L. et al. Enhanced immune reconstitution with albuvirtide in HIV-infected immunological non-responders. Front. Cell. Infect. Microbiol. 14, 1397743 (2024).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"5821_CR26","doi-asserted-by":"publisher","first-page":"e0247929","DOI":"10.1371\/journal.pone.0247929","volume":"16","author":"S Bayarsaikhan","year":"2021","unstructured":"Bayarsaikhan, S., Jagdagsuren, D., Gunchin, B., Sandag, T. & Survival CD4 T lymphocyte count recovery and immune reconstitution pattern during the first-line combination antiretroviral therapy in patients with HIV-1 infection in Mongolia. PLoS One. 16 (3), e0247929 (2021).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05821-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05821-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05821-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:57:34Z","timestamp":1751389054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05821-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5821"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05821-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical clearance was obtained from Ethics Committee of Henan Provincial Infectious Disease Hospital (IEC-KY-2023-34). This study was done by applying the principles of Declaration of Helsinki. All participants provided informed consent before participating in the study. The anonymity and confidentiality of the participants were guaranteed, and participation was completely voluntary.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"21322"}}